Abstract
This paper describes an improved design of artificial pancreas, which takes into account the physical parameters of human body for detecting hypoglycemic state of diabetic patients. In diabetes mellitus, failure in endogenous insulin production requires exogenous infusion of required drug amount. Traditionally, a closed-loop blood glucose level (BGL) control system includes a patient, continuous glucose monitor, controller and an insulin pump as the actuating device. Such systems are not perfectly safe to use as an overdose due to late action of insulin and/or delay in reading sensor data may lead to dangerously low blood sugar levels (hypoglycemia). Our design incorporates vital signs such as electrocardiogram, heart beat rate, electroencephalography and skin resistance for early detection and avoidance of hypoglycemia state. The objective is to securely control BGL of a patient suffering from diabetes and to prevent the harmful state of hypoglycemia. A typical proportional integrate derivative controller is designed for keeping glucose level inside the desired ‘safe’ range under normal conditions. Once hypoglycemia is detected, a specified amount of glucagon is infused into the patient’s body. The simulations have shown that patient safety can be improved through this strategy. In addition, the model-based design of the purposed system is validated by the UPPAAL model checker tool.
Similar content being viewed by others
Reference
Lee, I.; Sokolsky, O.: Medical cyber physical systems. In: Proceedings of DAC, Anaheim, California, USA (2010)
High Confidence Software and Systems Coordinating Group. High-confidence medical devices: Cyber-physical systems for 21st century health care. A Research and Development Needs Report, NCO/NITRD, February (2009)
World Health Organization. Fact Sheet N 138 (2011). http://www.who.int/mediacentre/factsheets/fs138/en/. Accessed 16 Aug 2011
Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329(14): 977–986 (1993)
Dua P, Doyle F.J, Pistikopoulos E.N: Model-based blood glucose control for type-1 diabetes via parametric programming. IEEE Trans. Biomed. Eng. 53, 1478–1491 (2006)
Bequette B.W: A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol. Ther. 7(1), 28–47 (2005)
Owens C, Zisser H, Jovanovic L, Srinivasan B, Bonvin D, Doyle J III: Run-to-run control of blood glucose concentrations for people with type-1 diabetes mellitus. IEEE Trans. Biomed. Eng. 53(6), 996–1005 (2006)
Dudde R, Vering T, Piechotta G, Hintsche R: Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin. IEEE Trans. Inf. Technol. Biomed. 10(2), 395–402 (2006)
Farmer T.G Jr., Edgar T.F, Peppas N.A: The future of open- and closed-loop insulin delivery systems. J Pharm. Pharmacol. 60(1), 1–13 (2008)
Bellazzi R, Nucci G, Cobelli C: The subcutaneous route to insulin dependent diabetes therapy. IEEE Eng. Med. Biol. 20, 54–64 (2001)
Clarke, E.M.; Emerson, E.A.: Design and synthesis of synchronization skeletons using branching-time temporal logic. In: Workshop on Logic of Programs, pp. 52–71 (1982)
Cryer P.E: Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45(7), 937–48 (2002)
Chee, E; Fernando, T.; van Heerden, P.V.: Simulation study on automatic blood glucose control. In: 7th Australian and New Zealand Intelligent Information Systems Conference (2001)
Carson, E.R.; Cobelli, C. (eds.) Modelling Methodology for Physiology and Medicine. Academic Press, San Diego (2001)
Weinzimer S.A, Steil G.M, Swan K.L, Dziura J, Kurtz N, Tamborlane W.V: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type-1 diabetes using an artificial pancreas. Diabetes Care. 31(5), 934–939 (2008)
Bergman R.N, Phillips L.S, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and β -cell glucose sensitivity from the response to intravenous glucose. J. Clin. Investig. 68(6), 1456–1467 (1981)
Kanoun, K.; Mamaghanian, H.; Khaled, N.; Alonso, D.A.: A real-time compressed sensing-based personal electrocardiogram monitoring system. In: Proceedings of the IEEE/ACM 2011 Design, Automation and Test in Europe Conference (DATE 2011), Grenoble, France, March 14–18 (2011)
Chee F, Savkin A.V, Fernando T.L, Nahavandi S: Optimal H∞ insulin injection control for blood glucose regulation in diabetic patients. IEEE Trans. Biomed. Eng. 52(10), 1625–1631 (2005)
Chen, J.; Cao, K.; Sun, Y.; Xiao, Y.; Su, X.: Continuous drug infusion for diabetes therapy: a closed-loop control system design. EURASIP J. Wirel. Commun. Netw. Article ID 495185 (2008)
Hovorka R: Continuous glucose monitoring and closed-loop systems. Diabet. Med. 23, 1–12 (2005)
G’omez, E.J.; P’erez, M.E.H.; Vering, T.: The INCA system: a further step towards a telemedical artificial pancreas. IEEE Trans. Inf. Technol. Biomed. 12(4) (2008)
Phee, H.K.; Tung, W.L.; Quek, C.: A personalised approach to insulin regulation using brain inspired neural semantic memory in diabetic glucose control. In: IEEE CEC (2007)
Borrello, M.A.; Sun, C.A.J.; Bequette, B.W.: A comparison of clinical control strategies for the hyperglycemia of injury and illness. In: American Control Conference (2010)
Abu-Khalaf, M., Chen, R., Turevskiy, A.: PID control design made easy. Matlab Digest
Matlab Simulink R. Documentation. http://www.mathworks.com/help/toolbox/slcontrol/ug/br684zf.html. Accessed 5 Sept (2011)
Renard E, Costalat G, Chevassus H, Bringer J: Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab. 32(5 Pt 2), 497–502 (2006)
Youssef J.E, Castle J, Ward W.K: A review of closed-loop algorithms for glycemic control in the treatment of type-1 diabetes. Algorithms 2, 518–532 (2009)
Imec website. http://www2.imec.be/be_en/press/imec-news/ecgpatch.html. Accessed 2 Feb 2012
Fang, J.; Tan, S.; Ahmed, B.; Berlian, D.; Cosic, I.: A PDA based ambulatory human skin resistance measuring system. In: Proceedings of the IASTED International Conference on Telehealth, Banff, Canada, 19–21 July (2005)
Heller S.R, Macdonald I.A: Physiological disturbances in hypoglycemia: effect on subjective awareness. Clin. Sci. 81, 1–9 (1991)
Gale E.A.M, Bennett T, MacDonald I.A, Holst J.J, Matthews J.A: The physiological effects of insulin-induced hypoglycemia in man: responses at differing levels of blood glucose. Clin. Sci. 65, 263–271 (1983)
Marques J.L et al.: Altered ventricular repolarisation during hypoglycaemic in patient with diabetes. Diabet. Med. 8, 648–654 (1997)
Nguyen, H.T.; Ghevondian, N.; Jones, T.W.: Real-time detection of nocturnal hypoglycemic episodes using a novel non-invasive hypoglycemia monitor. In: 31st Annual International Conference of the IEEE EMBS (2009)
Heger G, Howorka K, Thoma H, Tribl G, Zeitlhofer J: Monitoring set-up for selection of parameters for detection of hypoglycemia in diabetic patients. Med. Biol. Eng. Comput. 34(1), 69–75 (1996)
Koivikko M.L, Salmela P.I et al.: Effects of sustained insulin-induced hypoglycemia on cardiovascular autonomic regulation in type-1 diabetes. Diabetes. 54, 745–750 (2005)
Castle J.R, Engle J.M, Youseff J.E et al.: Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type-1 diabetes. Diabetes Care 33(6), 1282–1287 (2010)
Russo F, Ramponi G: Fuzzy methods for multisensor data fusion. IEEE Trans. Instrum. Meas. 43(2), 288–294 (1994)
Klonoff, D.C.: The artificial pancreas: how sweet engineering will solve bitter problems. J. Diabetes Sci. Technol. 1(1) (2007)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khan, S.H., Khan, A.H. & Khan, Z.H. Artificial Pancreas Coupled Vital Signs Monitoring for Improved Patient Safety. Arab J Sci Eng 38, 3093–3102 (2013). https://doi.org/10.1007/s13369-012-0456-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13369-012-0456-2